Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Farris

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Technology Assessment in Health Care|July 8, 2025
Stakeholder survey about broad elements of value in health technology assessment in Australia: industry and academia more similar than differentMaria Farris, Stephen Goodall, Richard De Abreu Lourenco
International Journal of Technology Assessment in Health Care|June 14, 2023
A systematic review of economic evaluations for <i>RPE65</i>-mediated inherited retinal disease including HTA assessment of broader valueMaria Farris, Stephen Goodall, Richard De Abreu Lourenco
Sexual Health|February 16, 2010
Triple-class HIV antiretroviral therapy failure in an Australian primary care settingMark Bloch, Maria Farris, Dominic Tilden, et al.
Pharmacoeconomics - Open|August 5, 2024
Estimating Australian Population Utilities for Inherited Retinal Disease Using Time Trade-OffMaria Farris, Stephen Goodall, Richard De Abreu Lourenco, et al.
Retina (Philadelphia, Pa.)|August 23, 2016
EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial DataKaty J L Bell, Andrew Hayen, Paul Glasziou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 14, 2026
Modeling SLE Treatment Cost-Effectiveness Based on a Novel LLDAS Treat-to-Target ApproachMaria Farris, Jenna Christensen, Vera Golder, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Technology Assessment in Health Care|July 8, 2025
Stakeholder survey about broad elements of value in health technology assessment in Australia: industry and academia more similar than differentMaria Farris, Stephen Goodall, Richard De Abreu Lourenco
International Journal of Technology Assessment in Health Care|June 14, 2023
A systematic review of economic evaluations for <i>RPE65</i>-mediated inherited retinal disease including HTA assessment of broader valueMaria Farris, Stephen Goodall, Richard De Abreu Lourenco
Sexual Health|February 16, 2010
Triple-class HIV antiretroviral therapy failure in an Australian primary care settingMark Bloch, Maria Farris, Dominic Tilden, et al.
Pharmacoeconomics - Open|August 5, 2024
Estimating Australian Population Utilities for Inherited Retinal Disease Using Time Trade-OffMaria Farris, Stephen Goodall, Richard De Abreu Lourenco, et al.
Retina (Philadelphia, Pa.)|August 23, 2016
EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial DataKaty J L Bell, Andrew Hayen, Paul Glasziou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 14, 2026
Modeling SLE Treatment Cost-Effectiveness Based on a Novel LLDAS Treat-to-Target ApproachMaria Farris, Jenna Christensen, Vera Golder, et al.
Pageof 1